ATE522813T1 - Verfahren für den nachweis karzinomatöser epithelzellen mittels freigesetzter zytokeratine als marker für diese zellen - Google Patents

Verfahren für den nachweis karzinomatöser epithelzellen mittels freigesetzter zytokeratine als marker für diese zellen

Info

Publication number
ATE522813T1
ATE522813T1 AT07825055T AT07825055T ATE522813T1 AT E522813 T1 ATE522813 T1 AT E522813T1 AT 07825055 T AT07825055 T AT 07825055T AT 07825055 T AT07825055 T AT 07825055T AT E522813 T1 ATE522813 T1 AT E522813T1
Authority
AT
Austria
Prior art keywords
cells
marker
released
detecting
cytokeratins
Prior art date
Application number
AT07825055T
Other languages
English (en)
Inventor
Catherine Panabieres
Klaus Pantel
Jean-Pierre Vendrell
Original Assignee
Universitaetsklinikum Hamburg
Ct Hospitalier Universitaire Montpellier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaetsklinikum Hamburg, Ct Hospitalier Universitaire Montpellier filed Critical Universitaetsklinikum Hamburg
Application granted granted Critical
Publication of ATE522813T1 publication Critical patent/ATE522813T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT07825055T 2006-09-07 2007-09-04 Verfahren für den nachweis karzinomatöser epithelzellen mittels freigesetzter zytokeratine als marker für diese zellen ATE522813T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84290206P 2006-09-07 2006-09-07
PCT/IB2007/002549 WO2008029251A2 (en) 2006-09-07 2007-09-04 Method for the detection of cancerous epithelial cells using released cytokeratins as markers for said cells

Publications (1)

Publication Number Publication Date
ATE522813T1 true ATE522813T1 (de) 2011-09-15

Family

ID=39027595

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07825055T ATE522813T1 (de) 2006-09-07 2007-09-04 Verfahren für den nachweis karzinomatöser epithelzellen mittels freigesetzter zytokeratine als marker für diese zellen

Country Status (5)

Country Link
US (1) US8524493B2 (de)
EP (1) EP2064552B1 (de)
AT (1) ATE522813T1 (de)
ES (1) ES2375453T3 (de)
WO (1) WO2008029251A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0815675D0 (en) 2008-08-28 2008-10-08 Mabtech Ab Antibody secreting cell elispot
JP6133297B2 (ja) * 2011-09-06 2017-05-24 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company 試料中の希少標的細胞のサイトメトリー検出のための方法及び組成物
CA2877721A1 (en) 2012-06-27 2014-01-03 Berg Llc Use of markers in the diagnosis and treatment of prostate cancer
EP3230314B1 (de) 2014-12-08 2023-05-03 Berg LLC Verwendung von markern einschliesslich filamin a bei der diagnose und behandlung von prostatakrebs
LU500787B1 (en) 2021-10-26 2023-04-27 Univ Hamburg Eppendorf Uke Isolation and detection of cdcp1 positive circulating tumor cells
LU501430B1 (en) 2022-02-09 2023-08-09 Univ Hamburg Eppendorf Uke Enrichment, detection and characterization of circulating tumor cells with susd2 and enpp1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003132A1 (en) 1984-01-06 1985-07-18 The Regents Of The University Of California Cytokeratin tumor markers and assays for their detection
DE3942999C2 (de) * 1989-12-27 1997-12-18 Progen Biotechnik Gmbh Verfahren zum Nachweis von malignen Erkrankungen
US20010039016A1 (en) * 2000-03-27 2001-11-08 Waldman Scott A. Use of expression profiling for identifying molecular markers useful for diagnosis of metastatic cancer
US20050079557A1 (en) 2002-03-13 2005-04-14 Bio Merieux Method for the detection and/or characterisation of circulating tumour cells and the use thereof in the early diagnosis, prognosis and diagnosis of relapses and in the selection and evaluation of therapeutic treatments
CA2498783A1 (en) 2002-09-12 2004-03-25 Yissum Research Development Company Of The Hebrew University Of Jerusale M Method for detection of micro-metastasis

Also Published As

Publication number Publication date
WO2008029251A2 (en) 2008-03-13
ES2375453T3 (es) 2012-03-01
US20100184083A1 (en) 2010-07-22
EP2064552B1 (de) 2011-08-31
WO2008029251A3 (en) 2008-05-22
EP2064552A2 (de) 2009-06-03
US8524493B2 (en) 2013-09-03

Similar Documents

Publication Publication Date Title
EP1922420A4 (de) Verfahren und substanzen zur isolierung von mirnas
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
EP2173467A4 (de) Verfahren und vorrichtung unter verwendung eines elektrischen felds für verbesserte biologische assays
MX2011004169A (es) Metodos para la separacion y caracterizacion de microorganismos utilizando agentes identificadores.
EA201390638A1 (ru) Обогащение и идентификация фетальных клеток в материнской крови и лиганды для такого применения
EA025172B9 (ru) Способ оценки способности достижения одним или более эмбрионами человека стадии бластоцисты
EP2074422A4 (de) Verfahren und kits für den nachweis von prostatakrebs-biomarkern
ATE552505T1 (de) Quantifizierbare interne referenzstandards für immunhistochemie und verwendung
DK2132339T3 (da) Fremgangsmåde til detektering af en analyt i en biologisk matrix
DE602006002809D1 (de) Verfahren zur erkennung eines ovarialkarzinoms
IN2014CN01970A (de)
BRPI0915619A2 (pt) métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra
ATE550645T1 (de) Verfahren zur zerstörungsfreien prüfung von rohren
GB201207297D0 (en) Analytical methods and arrays for use in the same
WO2008073895A3 (en) Methods and devices for testing saliva
ATE529738T1 (de) Verfahren zur zerstörungsfreien prüfung von rohren
MX2008013397A (es) Analisis de perfilamiento de expresion diferencial de fenotipos de cultivo celular y usos de los mismos.
ATE501166T1 (de) Isotopenmarkiertes einfangmittel und verfahren zur identifizierung reaktiver metaboliten
MX371379B (es) Deteccion de la actividad de corte de una enzima.
GB0814035D0 (en) Apparatus and method for biological sample culture or testing
DK2027447T3 (da) Apparat og fremgangsmåde til automatiseret reproducerbar fremstilling af celle- eller vævsprøver, der er anbragt på objektglas og skal undersøges
WO2008029251A3 (en) Method for the detection of cancerous epithelial cells using released cytokeratins as markers for said cells
GB201021623D0 (en) Detection of acute myeloid leukaemia
MX2007002908A (es) Sondas inmovilizadas y metodos para detectar proteinas prionicas alteradas conformacionalmente.
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2064552

Country of ref document: EP